Dr. Terese Catherine Hammond, MD

Dr. Hammond practices at Kaweah Health Medical Center in Visalia, California, part of Kaweah Delta Health Care District.

Dr. Hammond's NPI, 1407831829, was assigned on December 8, 2005. Dr. Hammond graduated from University of Missouri School of Medicine in 2000. Dr. Hammond holds California license C55366.

Dr. Hammond's primary practice is Kaweah Health Medical Center, at 400 W Mineral King Ave, Visalia, CA 93291 in Tulare County. The practice phone is (559) 624-2000.

Dr. Hammond's primary practice is Kaweah Health Medical Center in Visalia, California, part of Kaweah Delta Health Care District. The medical group on file is USC Care Medical Group. Dmand AI also links Dr. Hammond to 2 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hammond practices, 2 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Hammond's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Hammond is board certified in critical care medicine by the American Board of Internal Medicine. Dmand AI has Dr. Hammond's licenses on file in 2 states: California and Massachusetts.

CMS data shows 627 Medicare services from Dr. Hammond across 8 procedure codes in 2024, for 264 Medicare patients. Medicare paid $86,833 for them.

CMS counts 264 Medicare patients who saw Dr. Hammond in 2024. The largest group is 75 to 84, with 93 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 52% are also on Medicaid. Their average risk score is 3.04, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hammond's median patient age at 66, with 47% women.

In 2024, Dr. Hammond wrote 343 Medicare Part D claims for 64 patients. 57% of them were for generic drugs. CMS names the drug for 224 of them, across 8 drugs with 11 or more claims each, at $51,935 in total drug cost. In 2023, CMS named 65 claims across 4 drugs.

Dr. Hammond accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 9 papers to Dr. Hammond, published from 2020 to 2024. 2021 was the busiest year, with 4. The most frequent topics are COVID-19 and SARS-CoV-2. Dr. Hammond has published most often in Transl Med Commun. Dr. Hammond's most frequent co-authors are Santosh Kesari, MD, PhD, Gregory C. Kasper, MD and Christopher Lee Larson, MD.

Dmand AI links Dr. Hammond to 3 clinical trials. 1 is still active or recruiting. Conditions studied include Blood Loss, Surgical, Respiratory Distress Syndrome and Sleep Apnea, Obstructive.

CMS Open Payments shows 20 general payments to Dr. Hammond from 7 drug and device companies from 2016 to 2025. Honoraria make up the largest share, 67% of the total. Abiomed paid the most, $3,732.

Dr. Hammond graduated from University of Missouri School of Medicine in 2000.

Dr. Hammond is in network with 7 carriers, including Elevance, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.